Which has stronger earnings and valuation, WAY or HTFL?

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.31 $112.09M $0.70 35.29 Heartflow $176.03M 14.38 -$116.79M -$3.11 N/A

Is WAY or HTFL more profitable?

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -58.42%. Waystar's return on equity of 7.03% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Heartflow -58.42% N/A -20.02%

Does the media prefer WAY or HTFL?

In the previous week, Waystar and Waystar both had 1 articles in the media. Waystar's average media sentiment score of 1.34 beat Heartflow's score of 0.94 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, HTFL or DOCS?

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 14.38 -$116.79M -$3.11 N/A Doximity $655.57M 7.15 $196.05M $0.85 30.14

Is HTFL or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -58.42%. Doximity's return on equity of 18.06% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -58.42% N/A -20.02% Doximity 25.48% 18.06% 15.40%

Does the media favor HTFL or DOCS?

In the previous week, Doximity had 42 more articles in the media than Heartflow. MarketBeat recorded 43 mentions for Doximity and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat Doximity's score of 0.54 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 14 Very Positive mention(s) 4 Positive mention(s) 19 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, SDGR or HTFL?

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 5.42 -$103.26M -$0.74 N/A Heartflow $176.03M 14.38 -$116.79M -$3.11 N/A

Is SDGR or HTFL more profitable?

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -58.42%. Heartflow's return on equity of 0.00% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Heartflow -58.42% N/A -20.02%

Does the media prefer SDGR or HTFL?

In the previous week, Schrodinger had 13 more articles in the media than Heartflow. MarketBeat recorded 14 mentions for Schrodinger and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat Schrodinger's score of 0.58 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 3 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, HTFL or GDRX?

GoodRx has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 14.38 -$116.79M -$3.11 N/A GoodRx $796.85M 1.57 $30.44M $0.04 91.50

Is HTFL or GDRX more profitable?

GoodRx has a net margin of 2.07% compared to Heartflow's net margin of -58.42%. GoodRx's return on equity of 7.22% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -58.42% N/A -20.02% GoodRx 2.07% 7.22% 2.53%

Does the media prefer HTFL or GDRX?

In the previous week, GoodRx had 13 more articles in the media than Heartflow. MarketBeat recorded 14 mentions for GoodRx and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat GoodRx's score of 0.77 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 3 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, CERT or HTFL?

Certara has higher revenue and earnings than Heartflow. Certara is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 2.94 -$1.60M -$0.45 N/A Heartflow $176.03M 14.38 -$116.79M -$3.11 N/A

Is CERT or HTFL more profitable?

Certara has a net margin of -16.75% compared to Heartflow's net margin of -58.42%. Certara's return on equity of 3.86% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Heartflow -58.42% N/A -20.02%

Does the media refer more to CERT or HTFL?

In the previous week, Certara had 23 more articles in the media than Heartflow. MarketBeat recorded 24 mentions for Certara and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat Certara's score of 0.61 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 11 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Heartflow (HTFL) Competitors

$29.35 +0.53 (+1.84%)

As of 08/10/2026 04:00 PM Eastern

Compare

HTFL vs. WAY, DOCS, SDGR, GDRX, and CERT

Should you buy Heartflow stock or one of its competitors? Heartflow's main competitors and comparable companies include Waystar (WAY), Doximity (DOCS), Schrodinger (SDGR), GoodRx (GDRX), and Certara (CERT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Heartflow compare to Waystar?

Waystar (NASDAQ:WAY) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -58.42%. Waystar's return on equity of 7.03% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Heartflow	-58.42%	N/A	-20.02%

Waystar currently has a consensus price target of $35.23, indicating a potential upside of 42.62%. Heartflow has a consensus price target of $36.57, indicating a potential upside of 24.60%. Given Waystar's stronger consensus rating and higher probable upside, research analysts clearly believe Waystar is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	1 Sell rating(s)	2 Hold rating(s)	18 Buy rating(s)	3 Strong Buy rating(s)	2.96
Heartflow	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, Waystar and Waystar both had 1 articles in the media. Waystar's average media sentiment score of 1.34 beat Heartflow's score of 0.94 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.31	$112.09M	$0.70	35.29
Heartflow	$176.03M	14.38	-$116.79M	-$3.11	N/A

Summary

Waystar beats Heartflow on 12 of the 13 factors compared between the two stocks.

How does Heartflow compare to Doximity?

Heartflow (NASDAQ:HTFL) and Doximity (NYSE:DOCS) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Heartflow presently has a consensus target price of $36.57, suggesting a potential upside of 24.60%. Doximity has a consensus target price of $31.86, suggesting a potential upside of 24.34%. Given Heartflow's stronger consensus rating and higher possible upside, equities analysts plainly believe Heartflow is more favorable than Doximity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
Doximity	4 Sell rating(s)	12 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.25

87.2% of Doximity shares are owned by institutional investors. 7.7% of Heartflow shares are owned by company insiders. Comparatively, 31.8% of Doximity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	14.38	-$116.79M	-$3.11	N/A
Doximity	$655.57M	7.15	$196.05M	$0.85	30.14

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -58.42%. Doximity's return on equity of 18.06% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
Doximity	25.48%	18.06%	15.40%

In the previous week, Doximity had 42 more articles in the media than Heartflow. MarketBeat recorded 43 mentions for Doximity and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat Doximity's score of 0.54 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	14 Very Positive mention(s)	4 Positive mention(s)	19 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Doximity beats Heartflow on 11 of the 16 factors compared between the two stocks.

How does Heartflow compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

In the previous week, Schrodinger had 13 more articles in the media than Heartflow. MarketBeat recorded 14 mentions for Schrodinger and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat Schrodinger's score of 0.58 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	3 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -58.42%. Heartflow's return on equity of 0.00% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Heartflow	-58.42%	N/A	-20.02%

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	5.42	-$103.26M	-$0.74	N/A
Heartflow	$176.03M	14.38	-$116.79M	-$3.11	N/A

Schrodinger presently has a consensus target price of $20.25, suggesting a potential upside of 7.88%. Heartflow has a consensus target price of $36.57, suggesting a potential upside of 24.60%. Given Heartflow's stronger consensus rating and higher possible upside, analysts clearly believe Heartflow is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33
Heartflow	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

79.1% of Schrodinger shares are held by institutional investors. 10.1% of Schrodinger shares are held by company insiders. Comparatively, 7.7% of Heartflow shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Schrodinger and Heartflow tied by winning 8 of the 16 factors compared between the two stocks.

How does Heartflow compare to GoodRx?

Heartflow (NASDAQ:HTFL) and GoodRx (NASDAQ:GDRX) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

GoodRx has a net margin of 2.07% compared to Heartflow's net margin of -58.42%. GoodRx's return on equity of 7.22% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
GoodRx	2.07%	7.22%	2.53%

GoodRx has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	14.38	-$116.79M	-$3.11	N/A
GoodRx	$796.85M	1.57	$30.44M	$0.04	91.50

63.8% of GoodRx shares are owned by institutional investors. 7.7% of Heartflow shares are owned by insiders. Comparatively, 5.9% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Heartflow presently has a consensus target price of $36.57, indicating a potential upside of 24.60%. GoodRx has a consensus target price of $3.98, indicating a potential upside of 8.67%. Given Heartflow's stronger consensus rating and higher possible upside, equities research analysts plainly believe Heartflow is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

In the previous week, GoodRx had 13 more articles in the media than Heartflow. MarketBeat recorded 14 mentions for GoodRx and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat GoodRx's score of 0.77 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	3 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

GoodRx beats Heartflow on 9 of the 16 factors compared between the two stocks.

How does Heartflow compare to Certara?

Certara (NASDAQ:CERT) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

In the previous week, Certara had 23 more articles in the media than Heartflow. MarketBeat recorded 24 mentions for Certara and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat Certara's score of 0.61 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	11 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Certara has a net margin of -16.75% compared to Heartflow's net margin of -58.42%. Certara's return on equity of 3.86% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Heartflow	-58.42%	N/A	-20.02%

74.0% of Certara shares are held by institutional investors. 1.1% of Certara shares are held by insiders. Comparatively, 7.7% of Heartflow shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Certara has higher revenue and earnings than Heartflow. Certara is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	2.94	-$1.60M	-$0.45	N/A
Heartflow	$176.03M	14.38	-$116.79M	-$3.11	N/A

Certara presently has a consensus price target of $8.28, suggesting a potential upside of 2.57%. Heartflow has a consensus price target of $36.57, suggesting a potential upside of 24.60%. Given Heartflow's stronger consensus rating and higher probable upside, analysts clearly believe Heartflow is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Heartflow	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

Summary

Certara beats Heartflow on 8 of the 15 factors compared between the two stocks.

Get Heartflow News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HTFL vs. The Competition

Export

Metric	Heartflow	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.49B	$1.52B	$7.02B	$12.98B
Dividend Yield	N/A	4.71%	2.58%	10.07%
P/E Ratio	-9.44	23.86	269.20	24.72
Price / Sales	14.38	72.77	588.82	98.22
Price / Cash	N/A	30.51	28.89	37.42
Price / Book	8.31	5.35	11.27	6.42
Net Income	-$116.79M	-$25.90M	$3.45B	$347.03M
7 Day Performance	7.59%	5.68%	1.92%	0.69%
1 Month Performance	9.84%	3.06%	-0.58%	-0.90%
1 Year Performance	N/A	-14.72%	75.49%	21.87%

Heartflow Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HTFL Heartflow	3.1607 of 5 stars	$29.35 +1.8%	$36.57 +24.6%	N/A	$2.49B	$176.03M	N/A	699	Gap Up
WAY Waystar	4.4841 of 5 stars	$23.37 0.0%	$35.14 +50.3%	-28.6%	$4.48B	$1.21B	33.39	1,700	Positive News
DOCS Doximity	4.1908 of 5 stars	$20.63 -4.6%	$29.33 +42.2%	N/A	$3.77B	$644.86M	20.84	890	Earnings Report Analyst Downgrade Gap Down High Trading Volume
SDGR Schrodinger	1.436 of 5 stars	$17.81 +8.6%	$20.25 +13.7%	-2.3%	$1.31B	$254.91M	N/A	790	Earnings Report Analyst Upgrade High Trading Volume
GDRX GoodRx	3.5521 of 5 stars	$3.72 +13.8%	$3.98 +7.0%	+5.5%	$1.27B	$787.89M	62.01	950	Earnings Report High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HTFL) was last updated on 8/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Heartflow (HTFL) Competitors